Unsuccessful Arbitration Annulment Outcome
The information contained within this Announcement is deemed by Rockhopper Exploration plc to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of UK law by virtue of the European Union (Withdrawal) Act 2018 ("MAR").
Rockhopper Exploration plc
("Rockhopper" or the "Company")
Unsuccessful Arbitration Annulment Outcome
Rockhopper Exploration plc (AIM: RKH), the oil and gas company with key interests in the North Falkland Basin, provides the following update on its International Centre for Settlement of Investment Disputes ("ICSID") arbitration with the Republic of Italy.
Italy has succeeded in having the Award annulled. Under the terms of the Monetisation Agreement announced on 20 December 2023, the Tranche 2 payment will now be €0.
Rockhopper now intends to make a claim under the terms of an insurance policy announced on 14 October 2024, additional details of which are set out below.
The insurance policy ensures that, in the event that the Italian Republic succeeds in having the entire Award annulled or in the event of partial annulment, the combination of the Tranche 2 payment and the insurance payout shall entitle Rockhopper to a total no less than €31 million.
Rockhopper is in discussions with the specialist funder of the Monetisation Agreement regarding possible next steps.
Background
As announced on 24 August 2022, the arbitration panel unanimously held that Italy had breached its obligations under the Energy Charter Treaty (the "Award") entitling Rockhopper to compensation of €190 million plus interest at EURIBOR + 4%, compounded annually from 29 January 2016 until time of payment (except the four-month period immediately following the date of the Award).
On 28 October 2022, Italy submitted an application to the ICSID seeking to annul the Award under Article 52 of the ICSID Convention.
On 14 October 2024, Rockhopper announced it had decided, in line with normal market practice, that insuring to protect shareholders against loss resulting from an annulment of the Award was the most prudent course of action.
The insurance policy ensures that, in the event that the Italian Republic succeeds in having the entire Award annulled or in the event of partial annulment, the combination of the Tranche 2 payment and the insurance payout shall entitle Rockhopper to a total no less than €31 million.
The policy was placed via an FCA-registered specialist insurance brokerage. The policy was underwritten by a specialist underwriting agency and subscribed to by a number of A-rated insurance carriers and syndicates.
Sam Moody, Chief Executive Officer of Rockhopper Exploration, commented:
"Obviously we are disappointed with this outcome. Having already received the Tranche 1 monetisation payment our balance sheet remains robust and we intend to claim under the insurance policy. With a lead lending bank appointed, we now move to finalising the funding for Sea Lion FID which has the potential to unlock very significant value as confirmed in our recently published resource evaluation."
Enquiries:
Rockhopper Exploration plc
Sam Moody, Chief Executive Officer
Tel. +44 (0)20 7390 0234 (via Vigo Consulting)
Canaccord Genuity Limited (NOMAD and Joint Broker)
Henry Fitzgerald-O'Connor/James Asensio/Charlie Hammond
Tel. +44 (0) 20 7523 8000
Peel Hunt LLP (Joint Broker)
Richard Crichton/Georgia Langoulant
Tel. +44 (0) 20 7418 8900
Vigo Consulting
Patrick d'Ancona/Ben Simons/Fiona Hetherington
Tel. +44 (0) 20 7390 0234
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 39 minutes ago Prudential
- 50 minutes ago Vanquis Banking Group 20
- 3 hours ago Frasers Group
- 3 hours ago Cavendish Financial
- 3 hours ago Diaceutics